Bronconex Acticap

Krajina: Nový Zéland

Jazyk: angličtina

Zdroj: Medsafe (Medicines Safety Authority)

Aktívna zložka:

Mometasone furoate 400ug (anhydrous)

Dostupné z:

Organon (New Zealand) Limited

INN (Medzinárodný Name):

Mometasone furoate 400 µg (anhydrous)

Dávkovanie:

400 mcg/dose

Forma lieku:

Powder for inhalation

Zloženie:

Active: Mometasone furoate 400ug (anhydrous) Excipient: Lactose

Počet v balení:

Inhaler, metered, DPI, (sample), 14 dose units

Trieda:

Prescription

Typ predpisu:

Prescription

Výrobca:

MSD International GmbH (Singapore Branch)

Terapeutické indikácie:

Bronconex Acticap is indicated for prophylactic therapy in the management of patients with asthma of all severities, including patients who have been dependent upon either inhaled or systemically administered corticosteroids and non-corticosteroid-dependent patients inadequately controlled on other drug regimens.

Prehľad produktov:

Package - Contents - Shelf Life: Inhaler, metered, DPI, (sample) - 14 dose units - 18 months from date of manufacture stored at or below 25°C - Inhaler, metered, DPI - 30 dose units - 18 months from date of manufacture stored at or below 25°C - Inhaler, metered, DPI - 60 dose units - 18 months from date of manufacture stored at or below 25°C

Dátum Autorizácia:

2000-12-05